The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. EyePoint Pharmaceuticals Inc shares valued at $673,355 were purchased by ANTHONY P. ADAMIS on Oct 23 ’24. At $10.04 per share, ANTHONY P. ADAMIS acquired 67,100 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, David R. Guyer purchased 36,975 shares, netting a total of over 329,817 in proceeds.
Before that, DICICCO WENDY F had added 2,567 shares to its account. In a trade valued at $19,997, the Director bought EyePoint Pharmaceuticals Inc shares for $7.79 each. Upon closing the transaction, the insider’s holdings increased to 2,567 shares, worth approximately $0.12 million.
As published in their initiating research note from Scotiabank on October 16, 2024, EyePoint Pharmaceuticals Inc [EYPT] has been a Sector outperform. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of January 22, 2024, JP Morgan has initiated its “an Overweight” rating for EYPT. Earlier on November 02, 2023, Mizuho initiated its rating. Their recommendation was “a Buy” for EYPT stock.
Analyzing EYPT Stock Performance
During the last five days, there has been a drop of approximately -1.45%. Over the course of the year, EyePoint Pharmaceuticals Inc shares have dropped approximately -49.85%. Shares of the company reached a 52-week high of $30.99 on 02/08/24 and a 52-week low of $7.40 on 08/14/24. A 50-day SMA is recorded $9.44, while a 200-day SMA reached $14.42. Nevertheless, trading volume fell to 0.72 million shares from 0.76 million shares the previous day.
Support And Resistance Levels for EyePoint Pharmaceuticals Inc (EYPT)
According to the 24-hour chart, there is a support level at 11.13, which, if violated, would cause prices to drop to 10.66. In the upper region, resistance lies at 12.28. The next price resistance is at 12.96. RSI (Relative Strength Index) is 59.08 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.59, which suggests the price will decrease in the coming days. Percent R is at 50.37%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
